ANI Pharmaceuticals adds $300m revolving credit facility
ANI Pharmaceuticals finalized a $300 million credit agreement dated November 4, 2026, with JPMorgan Chase Bank as administrative agent and sole lead arranger.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed